Does ALTEPLASE Cause Haemorrhagic transformation stroke? 496 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 496 reports of Haemorrhagic transformation stroke have been filed in association with ALTEPLASE (Activase). This represents 3.9% of all adverse event reports for ALTEPLASE.
496
Reports of Haemorrhagic transformation stroke with ALTEPLASE
3.9%
of all ALTEPLASE reports
168
Deaths
127
Hospitalizations
How Dangerous Is Haemorrhagic transformation stroke From ALTEPLASE?
Of the 496 reports, 168 (33.9%) resulted in death, 127 (25.6%) required hospitalization, and 64 (12.9%) were considered life-threatening.
Is Haemorrhagic transformation stroke Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALTEPLASE. However, 496 reports have been filed with the FAERS database.
What Other Side Effects Does ALTEPLASE Cause?
No adverse event (2,456)
Off label use (1,752)
Gingival bleeding (1,018)
Cerebral haemorrhage (819)
Death (818)
Haemorrhage intracranial (615)
Angioedema (603)
Haemorrhage (536)
Drug ineffective (524)
Product storage error (371)
What Other Drugs Cause Haemorrhagic transformation stroke?
RIVAROXABAN (257)
ASPIRIN (213)
DABIGATRAN ETEXILATE (113)
CLOPIDOGREL BISULFATE (85)
TENECTEPLASE (49)
HEPARIN (47)
APIXABAN (41)
ENOXAPARIN (34)
ASPIRIN DL-LYSINE (33)
WARFARIN (28)
Which ALTEPLASE Alternatives Have Lower Haemorrhagic transformation stroke Risk?
ALTEPLASE vs ALTERNARIA ALTERNATA
ALTEPLASE vs ALTHIAZIDE
ALTEPLASE vs ALTHIAZIDE\SPIRONOLACTONE
ALTEPLASE vs ALUMINUM
ALTEPLASE vs ALUMINUM HYDROXIDE